Cvfg LLC Makes New $8.17 Million Investment in Cardinal Health, Inc. $CAH

Cvfg LLC purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 38,666 shares of the company’s stock, valued at approximately $8,171,000. Cardinal Health accounts for about 1.0% of Cvfg LLC’s holdings, making the stock its 23rd biggest holding.

Other institutional investors have also recently modified their holdings of the company. Nordea Investment Management AB grew its position in Cardinal Health by 328.3% during the fourth quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock worth $133,741,000 after buying an additional 494,731 shares during the period. Procyon Advisors LLC increased its holdings in Cardinal Health by 78.7% in the fourth quarter. Procyon Advisors LLC now owns 17,025 shares of the company’s stock valued at $3,499,000 after buying an additional 7,499 shares in the last quarter. Kornitzer Capital Management Inc. KS lifted its position in shares of Cardinal Health by 100.8% during the 4th quarter. Kornitzer Capital Management Inc. KS now owns 18,164 shares of the company’s stock valued at $3,733,000 after acquiring an additional 9,120 shares during the period. Bank of Nova Scotia boosted its stake in shares of Cardinal Health by 137.4% during the 3rd quarter. Bank of Nova Scotia now owns 393,474 shares of the company’s stock worth $61,760,000 after acquiring an additional 227,716 shares in the last quarter. Finally, Swiss Life Asset Management Ltd boosted its stake in shares of Cardinal Health by 73.3% during the 3rd quarter. Swiss Life Asset Management Ltd now owns 76,736 shares of the company’s stock worth $12,044,000 after acquiring an additional 32,464 shares in the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

Shares of CAH opened at $239.36 on Wednesday. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $243.21. The company has a market capitalization of $56.06 billion, a PE ratio of 36.60, a price-to-earnings-growth ratio of 1.17 and a beta of 0.49. The stock has a fifty day moving average of $210.43 and a two-hundred day moving average of $212.35.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.38. The business had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business’s revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the firm earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Wednesday, July 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is currently 31.50%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on CAH. Weiss Ratings downgraded Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th. Zacks Research lowered Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. TD Cowen raised their price target on Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a research report on Friday, May 1st. Evercore decreased their price objective on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research note on Monday, May 4th. Fifteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $247.80.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.